Gebelikte Kardiyovasküler Hastalıklar

Authors

İbrahim Halil Altıparmak

Synopsis

Cardiovascular system (CVS) diseases during pregnancy are the most significant indirect cause of maternal mortality, affecting approximately 1–4% of pregnant women. The Modified World Health Organization (mWHO) risk classification is utilized for risk assessment and management of CVS diseases during pregnancy, where pregnancy is considered contraindicated in mWHO Class IV diseases due to a high risk of morbidity and mortality (40–100%). While congenital heart diseases constitute two-thirds of CVS cases in pregnancy, the highest risk of complications and maternal mortality occurs in pulmonary hypertension and Eisenmenger syndrome. Among valvular diseases, left-sided stenotic lesions (mitral and aortic stenosis) are poorly tolerated during pregnancy due to increased cardiac output, and strict anticoagulation management and thrombosis monitoring are vital in pregnant women with mechanical prosthetic valves. Peripartum, dilated, and hypertrophic cardiomyopathies, along with severe left ventricular dysfunction (EF <30%), carry a high risk of feto-maternal complications and mortality. Furthermore, coronary artery diseases, acute myocardial infarction, aortopathies such as Marfan syndrome, atrial fibrillation as the most common arrhythmia, and hypertensive disorders like preeclampsia and eclampsia are major causes of adverse feto-maternal outcomes. Consequently, early detection of cardiovascular diseases, a multidisciplinary team approach, close hemodynamic monitoring, individualized delivery planning, and optimal management strategies are of critical importance for maternal and fetal health.

References

American College of Obstetricians and Gynecologists' Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease. Obstet Gynecol. 2019 May;133(5):e320-e356. doi: 10.1097/AOG.0000000000003243. PMID: 31022123.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340.

Türkiye Cumhuriyeti Sağlık Bakanlığı, Sağlık istatistikleri yıllığı, 2019 Haber Bülteni. 8, 1, 2020.

Engin-Üstün Y, Sanisoğlu S, Keskin HL, et al. Changing trends in the Turkish maternal deaths, with a focus on direct and indirect causes. Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:21-25

van Hagen IM, Boersma E, Johnson MR, et al. Global cardiac risk assessment in the registry of pregnancy and cardiac disease: Results of a registry from the European Society of Cardiology. Eur J Heart Fail 2016;18:523–533.

Roos-Hesselink JW, Ruys TP, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: Results of a registry of the European Society of Cardiology. Eur Heart J 2013;34:657–665.

Galiè N, Humbert M, Vachiery JL, et al; ESC Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317.

Mandalenakis Z, Rosengren A, Skoglund K, et al. Survivorship in children and young adults with congenital heart disease in Sweden. JAMA Intern Med 2017;177:224–230.

Sliwa K, van Hagen IM, Budts W, et al. Pulmonary hypertension and pregnancy outcomes: Data from the Registry of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology. Eur J Heart Fail 2016;18:1119–1128.

Marelli AJ, Ionescu-Ittu R, Mackie AS, et al. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation 2014;130:749–756.

Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). Eur Heart J. 2019 Dec 14;40(47):3848-3855. doi: 10.1093/eurheartj/ehz136.

Duan R, Xu X, Wang X, et al. Pregnancy outcome in women with Eisenmenger's syndrome: a case series from west China. BMC Pregnancy Childbirth. 2016 Nov 16;16(1):356. doi: 10.1186/s12884-016-1153-z.

-Presbitero P, Somerville J, Stone S, et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994 Jun;89(6):2673-6. doi: 10.1161/01.cir.89.6.2673.

Thiene G, Frescura C. Anatomical and pathophysiological classification of congenital heart disease. Cardiovasc Pathol. 2010 Sep-Oct;19(5):259-74. doi: 10.1016/j.carpath.2010.02.006.

Ahmed I, Anjum F. Atrioventricular Septal Defect. 2020 Dec 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; (2021).

Narin N. Ebstein Anomalisi: Tanı, İzlem ve Tedavi. Turkiye Klinikleri J Cardiol-Special Topics. 2008;1(5):74-7

Matsui H, Negoro S, Nishida S, et al. Right ventricular cardiomyopathy accompanied by protein-losing enteropathy and chylous effusion. Jpn Circ J. 2001 Oct;65(10):912-4.

Steckham KE, Bhagra CJ, Siu SC, et al. Pregnancy in Women With Repaired Truncus Arteriosus: A Case Series. Can J Cardiol. 2017 Dec;33(12):1737.e1-1737.e3. doi: 10.1016/j.cjca.2017.09.018.

Collins RT 2nd, Chang D, Sandlin A, et al. National In-Hospital Outcomes of Pregnancy in Women With Single Ventricle Congenital Heart Disease. Am J Cardiol. 2017 Apr 1;119(7):1106-1110. doi: 10.1016/j.amjcard.2016.12.015.

Hart EM, Maharaj R, Mushambi MC, et al. Uncorrected total anomalous pulmonary venous drainage in pregnancy. Int J Obstet Anesth. 2007 Apr;16(2):160-4. doi: 10.1016/j.ijoa.2006.10.010.

Stangl V, Bamberg C, Schröder T, et al. Pregnancy outcome in patients with complex pulmonary atresia: case report and review of the literature. Eur J Heart Fail. 2010 Feb;12(2):202-7. doi: 10.1093/eurjhf/hfp192.

Zühlke L, Engel ME, Karthikeyan G, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J. 2015 May 7;36(18):1115-22a. doi: 10.1093/eurheartj/ehu449.

van Hagen IM, Roos-Hesselink JW, Ruys TP, et al; ROPAC Investigators and the EURObservational Research Programme (EORP) Team*. Pregnancy in Women With a Mechanical Heart Valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 2015 Jul 14;132(2):132-42. doi: 10.1161/CIRCULATIONAHA.115.015242.

Goldstein SA, Ward CC. Congenital and Acquired Valvular Heart Disease in Pregnancy. Curr Cardiol Rep. 2017 Aug 24;19(10):96. doi: 10.1007/s11886-017-0910-6.

Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001 Mar 1;37(3):893-9. doi: 10.1016/s0735-1097(00)01198-0.

van Hagen IM, Thorne SA, Taha N, et al; ROPAC Investigators and EORP Team. Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease. Circulation. 2018 Feb 20;137(8):806-816. doi: 10.1161/CIRCULATIONAHA.117.032561.

Orwat S, Diller GP, van Hagen IM, et al; ROPAC Investigators. Risk of Pregnancy in Moderate and Severe Aortic Stenosis: From the Multinational ROPAC Registry. J Am Coll Cardiol. 2016 Oct 18;68(16):1727-1737. doi: 10.1016/j.jacc.2016.07.750. Erratum in: J Am Coll Cardiol. 2017 Feb 7;69(5):601.

Vause S, Clarke B, Tower CL, et al; (on behalf of UKOSS). Pregnancy outcomes in women with mechanical prosthetic heart valves: a prospective descriptive population based study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection system. BJOG. 2017 Aug;124(9):1411-1419. doi: 10.1111/1471-0528.14478.

Arany Z, Elkayam U. Peripartum Cardiomyopathy. Circulation. 2016 Apr5;133(14):1397-409.doi: 10.1161/CIRCULATIONAHA.115.020491.

Walenta K, Schwarz V, Schirmer SH, et al. Circulating microparticles as indicators of peripartum cardiomyopathy. Eur Heart J. 2012 Jun;33(12):1469-79.

Hilfiker-Kleiner D, Haghikia A, Masuko D, et al. Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. Eur J Heart Fail. 2017 Dec;19(12):1723-1728. doi: 10.1002/ejhf.808.

Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.

Metra M. September 2016 at a glance: pregnancy, hypertrophic cardiomyopathy, epidemiology, medical treatment. Eur J Heart Fail. 2016 Sep;18(9):1091-2. doi: 10.1002/ejhf.627.

Vaidya VR, Arora S, Patel N, et al. Burden of Arrhythmia in Pregnancy. Circulation. 2017 Feb 7;135(6):619-621. doi: 10.1161/CIRCULATIONAHA.116.026681.

Hindricks G, Potpara T, Dagres N, et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612. PMID: 32860505.

Brugada J, Katritsis DG, Arbelo E, et al; ESC Scientific Document Group. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720. doi: 10.1093/eurheartj/ehz467. Erratum in: Eur Heart J. 2020 Nov 21;41(44):4258.

Priori SG, Blomström-Lundqvist C, Mazzanti A, et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015 Nov 1;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316.

Habib G, Lancellotti P, Antunes MJ, et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015 Nov 21;36(44):3075-3128. doi: 10.1093/eurheartj/ehv319.

Williams B, Mancia G, Spiering W, et al; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. Erratum in: Eur Heart J. 2019 Feb 1;40(5):475.

Pages

39-58

Published

November 17, 2021

License

License